Testicular relapse in acute lymphoblastic leukaemia: studies with an experimental mouse model. by Jackson, H. et al.
Br. J. Cancer (1984), 49, 73-78
Testicular relapse in acute lymphoblastic leukaemia: Studies
with an experimental mouse model
H. Jackson, N.C. Jackson, M. Bock & M. Lendon'
Department ofPharmacology, University ofManchester, Manchester, M13 9PT and 'Department of
Pathology, University ofManchester and Royal Manchester Children's Hospital, Pendlebury, Manchester.
Summary Neither testis nor epididymis was found to be invaded by L1210 leukaemic cells in spite of
widespread dissemination through other organs and tissues. The same applied to animals in relapse after
protracted remissions induced by cyclophosphamide. Prior damage to the gonadal vascular endothelium by
Cd+ + did enable leukaemic cells to enter the testicular interstitium, but not the depleted seminiferous tubules.
Injection of cells into the lymphatic sinus system of the testis led to rapid peritubular proliferation and
systemic dissemination but the seminiferous tubules were not penetrated. The histological appearance
resembled that ofhuman ALL.
The results suggest that the L1210 system, using the intratesticular route for inoculation can be used to
examine the susceptibility to drugs of leukaemic cells in this environment. The potential of drugs to damage
the vascular endothelium of the gonad and perhaps contribute to the development of testicular relapse could
be assessed following intramuscular inoculation ofcells.
The development of more effective chemo-
therapeutic agents for the treatment of acute
lymphoblastic leukaemia (ALL) about 25 years ago,
led to the recognition that increased life expectancy
was associated with relapse and signs and
symptoms of meningitis, a meningeal syndrome,
even during complete haematological remission
(Gilbert & Rice, 1957). This new phenomenon was
shown to be due to invasion of the meninges by
malignant lymphoblasts, also present in the
cerebrospinal fluid. The circumstances of
penetration of meninges and brain by these cells
and their relative immunity from drug therapy was
thoroughly investigated with particular reference to
the routes of invasion and the normal vascular
barriers, using both autopsy material and an
experimental mouse model, the L1210 leukaemia
(Thomas, 1965; Thomas et al., 1962).
Effective clinical control of meningeal leukaemia
was achieved by radiotherapy (Hustu et al., 1973)
and during the last ten years cerebral irradiation
has become an integral part of the routine
treatment of ALL. With the continuing availability
of more effective antileukaemic drugs, there has
recently been much concern about the increasing
manifestation of testicular involvement in the
leukaemic process with the implication that this
organ could also comprise a protected environment
for leukaemic cells from which systemic re-invasion
can occur. A survey of the clinical literature has
recently appeared (Tiedemann et al., 1982). Besides
the brain .and meninges, the thymus and testis
received early mention as possible "pharmacological
sanctuaries" (Rall, 1969), but no supporting
experimental evidence for the gonadal site appears
to have been published.
This paper describes the results of attempts to
use the L1210 mouse leukaemia as a model system
for the study of testicular relapse in relation to
vascular and cellular barriers, in order to
investigate the prospects of effective chemotherapy
and hopefully avoid therapy by testicular
irradiation with permanent destruction of germ cells
(Tiedemann et al., 1982). Success will depend upon
the development and application of
chemotherapeutic agents able to gain access to the
reproductive tract and destroy leukaemic cells
without irreversible damage to the seminiferous
epithelium and Leydig cells. That the testicular
vasculature and limiting membrane of the
seminiferous tubules can provide discriminatory
boundaries in relation to the entry of both
physiological and pharmacological agents (see
Setchell & Wallace, 1972; Okumura et al., 1975)
gives substance to the possibility of achieving a
selective chemotherapeutic objective.
Materials and methods
The L1210 leukaemia was kindly supplied by the
ICRF laboratory in London and maintained in
BDF, mice ( 25 g) by serial weekly passage.
Routinely, a saline suspension from the spleen
(50pl, 105 cells) was given i.m. into the hind
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limb, resulting in a survival time of 7-8 days. Even
2pd of this same cell suspension intramuscularly
resulted in a fatal outcome after 9-11 days so that
the number of leukaemic cells injected was
obviously far from critical. This small volume was
subsequently used for intratesticular injections into
the lymphatic sinus system.
Cyclophosphamide (100mg vials of Endoxana)
was dissolved in 4ml of sterile water and diluted to
give the dosage required in 4mlkg-1, administered
I.P.
For histological examination the testes were fixed
in Bouins fluid for 24h, followed by 70% ethanol.
Other tissues were fixed in 10% formol-saline and
all carried through conventional processing to
paraffin wax. Sections were cut at 5pm and stained
with haemalum and eosin.
Results and discussion
As is well known, L1210 tumour cells in DBA or
BDF1 mice are highly malignant, irrespective of
route of injection, with 100% lethal outcome in 7-
10 days, depending on the number of cells
inoculated. The cause of the acute death seems not
to have been established so far as biochemical
parameters in the BDF1 mouse are concerned.
Subsequent to i.m. inoculation, a locally invasive
tumour develops (Figure 1) accompanied by
extensive systemic involvement of bone marrow and
spleen with a variable degree of infiltration of liver
and kidney (Figure 2). No indication could be
found of invasion of testicular or epididymal
interstitium even in the terminal phase (Figure 3)
although there was evidence of leukaemic cells in
the testicular blood vessels. In view of the rapid
progression of the disease there could have been
inadequate time for leukaemic cells to penetrate
these, especially in view of the reputed "tight"
junctions between the vascular endothelial cells.
Nevertheless the testicular capillary wall is known
to be readily crossed by many substances, including
iodinated albumin, so reaching testicular lymph
(Setchell et al., 1969). Only in the ascitic form of
the leukaemia, produced by i.p. inoculation of cells,
was invasion of part of the epididymis and vas
deferens seen (Figure 4) but the testis remained
clear.
As with the testis and epididymis of mice bearing
the L1210 leukaemia, we found no indication of
infiltration of meninges or cerebral tissue as has
been previously reported. Methotrexate treatment
in the advanced stage of the disease could produce
a twofold increase in lifespan (Thomas et al., 1964),
in which case meningeal leukaemia developed.
Actual invasion of cerebral tissue was not a feature.
Progressive growth and infiltration occurred in both
dura and arachnoid during treatment with
methotrexate. After intracerebral inoculation with
L1210 cells the suggestion was that spread to
extracranial organs occurred by the haematogenous
route or direct extensions outwards through tissues
surrounding cranial and spinal nerves and blood
vessels (Thomas et al., 1962). Cyclophosphamide
(s.c.) prolonged the mean survival time in such mice
by completely destroying the leukaemic cells in
liver, spleen, bone marrow and dura, whereas those
in the subarachnoid space continued to proliferate.
A "therapeutic barrier" was referred to where the
systemic effect of cyclophosphamide ceased "so far
as intracranial tissues are concerned", because
insufficient drug passed the blood-brain and
cerebrospinal-blood barriers.
Thus the situation in the brain and meninges is
more complex than in the testis. In the latter organ
are two barrier components. The drug-permeable
vascular bed is surrounded in mouse and rat by a
lymph sinusoidal network containing groups of
Leydig cells. The lymph bathes the seminiferous
tubules, the walls of which comprise a combination
of myoid and Sertoli cells, most of the cytoplasm of
the latter cells lying within the tubules (Fawcett, et
al., 1973).
In the current work, the possibility of a testicular
environment unfavourable to L1210 cell growth
was eliminated by intratesticular injection of cells
into the lymphatic sinusoidal system (2,ul
containing about 5 x103 cells). Rapid peritubular
cell-growth followed, associated with testicular
enlargement. The seminiferous tubules did not
appear to be directly invaded but rather destroyed
by a process of attrition (Figures 5 and 6). The
overall picture closely resembled that seen in
children with ALL. There was, too, a rapid
systematic spread from the testis resulting in death
at times comparable to those following injection of
the same number of tumour cells by the
intramuscular route. The contralateral testis was
not invaded.
Extension of the survival time was achieved using
single doses of cyclophosphamide. The ED50 for
the drug was determined using an i.p. injection
administered on day 3 post-inoculation (i.m.) of
L1210 cells, with 10 mice per group. There was one
long-term survivor at 30mgkg-1, whilst doses of
60, 80 and 90mgkg-1 yielded 50% surviving
beyond 9-12 months. Doses of 100mgkg-1 and
upwards resulted in 100% survival.
Dose-response studies had been reported by
Goldin (1969) with the L1210 leukaemic in BDF1
mice but using 107 cells per inoculum
subcutaneously. Cyclophosphamide was also
injected s.c. on day 3 and survival assessed up to 60
days. There were no survivors up to 120mgkg-1,Figure 1 Invasion of voluntary muscle by L1210
cells in the region of the inoculum. ( x 200).
Figure 2 Focal infiltration of the kidney by
leukaemic cells. (x 100).
A.
::.1
Figure 3 No leukaemic invasion of the testis in
the terminal stage of the disease (i.m. or i.v.
inoculation). (x 100).
Figure 4 Subcapsular invasion of the epididymis
and vas deferens by L1210 cells following i.p.
inoculation (11 days). The testis was not involved.
The main 8 forms' structure shown appears to be
part of the pad containing the ductuli efferentes
and lymphatics. ( x 40).
75Figure 5 Extensive peritubular growth of L1210
cells injected directly into the testicular lymphatic
sinus system. The seminiferous tubules are not
invaded. (x 100).
Figure 6 Malignant lymphoblasts arrange
themselves as a palisade of cells around the
seminiferous tubule. The seminiferous epithelium
undergoes atrophy (intratesticular inoculation).
( x 400).
Figure 7 Peritubular invasion of the cadmium Figure 8 As Figure 7. Note the total destruction
chloride-treated mouse testis by L1210 cells of the seminiferous epithelium by the cadmium ion,
subsequent to i.m. inoculation and systemic but leukaemic cells were not seen within the
dissemination. (x 100). tubules. ( x 200).
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and only 50% between doses of 245 and
350mgkg-1, after which the toxicity of the drug
itself operated so that no animals survived at
500mgkg-1. More recently using the same
leukaemia in DBA mice with an i.p. inoculation of
3 x 106 cells from the ascitic form of the disease, no
therapeutic effect was observed with
cyclophosphamide (50mgkg-1i.p.) given on day 1
and repeated on day 8 (Page et al., 1977). The
difference between these results and the high cure
rate in the present work is presumably related to
the size of inoculum and/or route of administration
of the cyclophosphamide (Goldin, 1969). However,
in the current series, the onset of relapse was
associated with the development of local tumour at
the original site of inoculation, but its presence did
not seem to herald the usual rapid systematic
dissemination of the leukaemia. A number of such
animals (6) were examined in the period of relapse,
again with no evidence of testicular involvement,
although leukaemic infiltration occurred in spleen,
liver and kidney. Cell suspensions from the local
tumours did produce the characteristic, rapidly
progressive disease.
It seemed therefore, that damage to the vascular
endothelium within the testis was a requisite for
testicular invasion in this mouse model. Evidence
was first sought by local irradiation of the gonads
(10Gy, linear accelerator) followed by i.m.
inoculation with L1210 cells after 24h or 7 days,
but in neither instance did testicular invasion occur.
The cadmium ion is well known to damage the
vascular endothelium of the testis in scrotal
mammals (Waites & Setchell, 1966; Hark6nen &
Kormano, 1970). We first carried out dose-response
studies in BDF1 mice which showed that whereas a
dose of 0.01 mM of aqueous cadmium chloride
(- 3mgkg-1) produced extensive testicular damage,
0.005mM was ineffective. Inoculation with L1210
cells one week after the higher dose of cadmium
salt did lead to distinct focal infiltration of the
interstitium (Figures 7 & 8), with the implication
that damage to the capillary endothelium was a
prior requisite to penetration by L1210 cells. It is
interesting that the leukaemic cells were still unable
to penetrate the wall of the damaged seminiferous
tubules.
The direct use of the L1210 mouse model for the
study of testicular relapse is thus deficient because
of the inability of circulating malignant
lymphoblasts to penetrate the vascular endothelium
within the testis. However, there is a distinct
possibility that therapeutic agents alone or in
combination may damage the vascular endothelium
and thus facilitate testicular invasion and promote
testicular relapse. This may be relevant to the
varied incidence of testicular relapse in different
centres of treatment (Tiedemann et al., 1982). The
L1210 mouse model might still provide a useful test
system for discerning such potential, so that
histological examination of the testis and
epididymis using this leukaemia could be applied to
screening procedures for new drugs; an examination
of those currently in therapeutic use might well be
worthwhile.
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